Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.62 |
| ▸ | CCR8 | P51685 | 5/20 | 0.62 |
| ▸ | CCR5 | P51681 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.62 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MMP2 | P08253 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | MMP8 | P22894 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | MTOR | P42345 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1071707 | 0.83 | NR4A2 (0.59) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| Phenanthroline SCHEMBL7613395 | 0.81 | CCR1 (0.57) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| Phenanthroline SCHEMBL8357993 | 0.81 | CCR1 (0.57) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| SCHEMBL30913269 | 0.81 | NR4A2 (0.55) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| SCHEMBL8632444 | 0.80 | CCR1 (0.55) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| SCHEMBL16550178 | 0.79 | LMNA (0.56) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| Phenanthroline SCHEMBL1232224 | 0.79 | CCR1 (0.89) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| Phenanthroline SCHEMBL31549890 | 0.79 | CCR1 (0.89) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| Phenanthroline SCHEMBL8690798 | 0.79 | CCR1 (0.89) | CCR1CCR8CCR5L3MBTL1HSP90AA1 | |
| Phenanthroline SCHEMBL11542337 | 0.79 | CCR1 (0.89) | CCR1CCR8CCR5L3MBTL1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11673100-B2 | Systems and methods for integrated solar photodialysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-13 | — | — | US | disclosed |
| US-11673100-B2 | Systems and methods for integrated solar photodialysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-13 | — | — | US | disclosed |
| EP-3246963-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2023-05-31 | — | — | EP | disclosed |
| US-11318424-B2 | Light-driven ion-pumping membrane systems | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-03 | — | — | US | disclosed |
| EP-3693372-A1 | BENZOFURO[3',2':4,5]IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC LIGHT-EMITTING DEVICES (OLEDS) | Samsung Display Co., Ltd. (KR) | 2020-08-12 | — | — | EP | disclosed |
| US-20190217255-A1 | SYSTEMS AND METHODS FOR INTEGRATED SOLAR PHOTODIALYSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-07-18 | — | — | US | disclosed |
| US-20180065095-A1 | LIGHT-DRIVEN ION-PUMPING MEMBRANE SYSTEMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-03-08 | — | — | US | disclosed |
| US-20180065095-A1 | LIGHT-DRIVEN ION-PUMPING MEMBRANE SYSTEMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-03-08 | — | — | US | disclosed |
| US-9573117-B2 | Catalyst precursors, catalysts and methods of producing same | INSTITUTE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2017-02-21 | — | — | US | disclosed |
| EP-2634178-B1 | QUINAZOLINE DERIVATIVE AND QUINAZOLINE COMPLEX PROTEIN KINASE INHIBITOR FOR INHIBITING MULTIPLICATION OF TUMOR CELLS AND PREPARATION METHOD THEREOF | CHINESE ACAD INST CHEMISTRY (CN) | 2016-08-24 | — | — | EP | disclosed |
| US-20140099571-A1 | CATALYSTS MADE USING THERMALLY DECOMPOSABLE POROUS SUPPORTS | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2014-04-10 | — | — | US | disclosed |
| EP-2673084-A1 | CATALYSTS MADE USING THERMALLY DECOMPOSABLE POROUS SUPPORTS | Institut National De La Recherche Scientifique (CA) | 2013-12-18 | — | — | EP | disclosed |
| US-8580704-B2 | Catalyst precursors, catalysts and methods of producing same | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2013-11-12 | — | — | US | disclosed |
| EP-2634178-A1 | QUINAZOLINE DERIVATIVE AND QUINAZOLINE COMPLEX PROTEIN KINASE INHIBITOR FOR INHIBITING MULTIPLICATION OF TUMOR CELLS AND PREPARATION METHOD THEREOF | Institute Of Chemistry, Chinese Academy Of Sciences (CN) | 2013-09-04 | — | — | EP | disclosed |
| US-20130225811-A1 | QUINAZOLINE DERIVATIVES AND QUINAZOLINE COMPLEX PROTEIN KINASE INHIBITOR FOR INHIBITING MULTIPLICAITON OF TUMOR CELLS AND PREPARATION METHOD THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCE (CN) | 2013-08-29 | — | — | US | disclosed |
| US-20130225811-A1 | QUINAZOLINE DERIVATIVES AND QUINAZOLINE COMPLEX PROTEIN KINASE INHIBITOR FOR INHIBITING MULTIPLICAITON OF TUMOR CELLS AND PREPARATION METHOD THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCE (CN) | 2013-08-29 | — | — | US | disclosed |
| US-20130071742-A1 | LITHIUM ION BATTERIES | GM Global Technology Operations LLC (US) | 2013-03-21 | — | — | US | disclosed |
| WO-2012107838-A1 | CATALYSTS MADE USING THERMALLY DECOMPOSABLE POROUS SUPPORTS | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2012-08-16 | — | — | WO | disclosed |
| US-20110294658-A1 | CATALYST PRECURSORS, CATALYSTS AND METHODS OF PRODUCING SAME | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2011-12-01 | — | — | US | disclosed |
| WO-2010051619-A1 | CATALYST PRECURSORS, CATALYSTS AND METHODS OF PRODUCING SAME | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2010-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225811-A1 | QUINAZOLINE DERIVATIVES AND QUINAZOLINE COMPLEX PROTEIN KINASE INHIBITOR FOR INHIBITING MULTIPLICAITON OF TUMOR CELLS AND PREPARATION METHOD THEREOF | MAP3K21, MAP3K15, MAP3K14 | CCR1 2770/4885CCR8 3215/4885CCR5 1932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.